Literature DB >> 26851042

Prognostic Significance of Preoperative Urine Cytology in Low-grade Non-muscle-invasive Bladder Cancer.

Keijiro Kiyoshima1, Masakazu Akitake1, Masaki Shiota1, Ario Takeuchi1, Ryosuke Takahashi1, Junichi Inokuchi1, Katsunori Tatsugami1, Akira Yokomizo2, Masatoshi Eto1.   

Abstract

AIM: To examine the clinical significance of preoperative urine cytology in patients with low-grade bladder cancer. PATIENTS AND METHODS: We retrospectively investigated the records of 155 patients diagnosed with primary low-grade (Ta) urothelial carcinoma of the bladder between January 2000 and September 2014.
RESULTS: Patients with class III or greater cytology had significantly higher-grade (G2) (p=0.01), larger tumors (≥15 mm, p=0.0009) and significantly shorter recurrence-free survival compared to patients with class II or lower cytology (p<0.0001). However, Cox proportional hazards analysis for recurrence-free survival only identified tumor size (≥15 mm) (hazard ratio=5.97, 95% confidence interval=2.39-17.29; p<0.0001) as a predictor of poor prognosis, although patients with class III or higher preoperative cytology showed a tendency towards frequent intravesical recurrence (hazard ratio=1.98, 95% confidence interval=0.96-4.2; p=0.063).
CONCLUSION: Preoperative urine cytology, in addition to tumor size, might be a useful predictor of intravesical recurrence of bladder cancer. Copyright
© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Urine cytology; bladder cancer; low-grade urothelial carcinoma

Mesh:

Year:  2016        PMID: 26851042

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Matrix Metalloproteinase 11 is a Potential Biomarker in Bladder Cancer Diagnosis and Prognosis.

Authors:  Chen Chen; Xiaoping Liu; Jiazhi Jiang; Shenjuan Li; Gang Wang; Lingao Ju; Fubing Wang; Tongzu Liu; Sheng Li
Journal:  Onco Targets Ther       Date:  2020-09-11       Impact factor: 4.147

2.  Knockdown of SLC35F2 Inhibits the Proliferation and Metastasis of Bladder Cancer Cells.

Authors:  Mei Chen; Xin Gao; Denggao Huang; Shunlan Wang; Linlin Zheng; Yinyi Chen; Xiaohong Wen; Yuanhui Gao; Hui Cao; Shufang Zhang
Journal:  Onco Targets Ther       Date:  2019-12-10       Impact factor: 4.147

3.  Prognostic value of CLIC3 mRNA overexpression in bladder cancer.

Authors:  Mei Chen; Shufang Zhang; Xiaohong Wen; Hui Cao; Yuanhui Gao
Journal:  PeerJ       Date:  2020-01-06       Impact factor: 2.984

4.  RPN2 Predicts Poor Prognosis and Promotes Bladder Cancer Growth and Metastasis via the PI3K-Akt Pathway.

Authors:  Chenglin Han; Shuxiao Chen; Haiyang Ma; Xiangchuan Wen; Zilong Wang; Yingkun Xu; Xunbo Jin; Xiao Yu; Muwen Wang
Journal:  Onco Targets Ther       Date:  2021-03-03       Impact factor: 4.147

5.  KIF22 promotes bladder cancer progression by activating the expression of CDCA3.

Authors:  Kai Li; Song Li; Shuai Tang; Minghao Zhang; Zhen Ma; Qi Wang; Fangmin Chen
Journal:  Int J Mol Med       Date:  2021-10-11       Impact factor: 4.101

6.  Preoperative positive voided urine cytology predicts poor clinical outcomes in patients with upper tract urothelial carcinoma undergoing nephroureterectomy.

Authors:  Wen Liu; Zhankun Wang; Shuai Liu; Yu Yao; Yong Liu; Guiming Zhang
Journal:  BMC Cancer       Date:  2020-11-16       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.